Therapy of adrenal insufficiency: an update (Q38062413)

28 August 2017

1 reference

title

Therapy of adrenal insufficiency: an update (English)

1 reference

28 August 2017

adrenal insufficiency

1 reference

Alberto Falorni

1

1 reference

PubMed ID

23179775

28 August 2017

Viviana Minarelli

series ordinal

2

1 reference

PubMed ID

23179775

28 August 2017

Silvia Morelli

series ordinal

3

1 reference

28 August 2017

21 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

43

1 reference

28 August 2017

514-528

1 reference

28 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9835-4

28 August 2017

0 references

cites work

Clinical review 130: Addison's disease 2001.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Eighty-six cases of Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

The prevalence of Addison's disease in Coventry, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

High prevalence and increasing incidence of Addison's disease in western Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21-Hydroxylase, a major autoantigen in idiopathic Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

On the front of X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

DAX1: Increasing complexity in the roles of this novel nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Endocrine organs under the control of the immune system: potential implications for cellular therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Association of Addison's disease with autoimmune disorders--a long-term observation of 180 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Autoimmune polyendocrine syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Newborn screening for congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21 January 2018

Secondary hypoadrenalism

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21 January 2018

Autoimmune hypophysitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Corticosteroid insufficiency in acutely ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Replacement therapy in Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21 January 2018

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Assessing the HPA axis in patients with pituitary disease: a UK survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Heritability of variation of plasma cortisol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Salivary cortisol in top-level professional soccer players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Current status of salivary hormone analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Salivary cortisone is a potential biomarker for serum free cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Salivary steroid assays - research or routine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Cushing's Syndrome: important issues in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Continuous subcutaneous hydrocortisone infusion in Addison's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Lemon juice alters cortisol assays in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Stability of salivary steroids: the influences of storage, food and dental care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Salivary cortisol levels in Brazilian citizens of distinct socioeconomic and cultural levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Salivary cortisol, dehydroepiandrosterone, and testosterone interrelationships in healthy young males: a pilot study with implications for studies of aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Adrenal crisis in treated Addison's disease: a predictable but under-managed event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Diagnosis and management of Addison’s disease during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Physiological importance of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Premature mortality in patients with Addison's disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

The epidemiology of glucocorticoid-associated adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Recognizing and treating secondary osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Long-term follow-up of bone mineral density in Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Co-morbidities, management and clinical outcome of auto-immune Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Risk of hip fracture in Addison's disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Subjective health status in Norwegian patients with Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Development of a disease-specific quality of life questionnaire in Addison's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Modified-release hydrocortisone to provide circadian cortisol profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Oxidative phosphorylation defect associated with primary adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

The Relationship between Smoking Status and Cortisol Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Addison Disease in Adults: Diagnosis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9835-4

Association of genetic polymorphisms and autoimmune Addison's disease

21 January 2018

1 reference

12 December 2020

Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations

1 reference

12 December 2020

Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease

1 reference

12 December 2020

Measurement of cortisol in human hair as a biomarker of systemic exposure.

1 reference

12 December 2020

I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease

1 reference

12 December 2020

Autoimmune Addison's disease and 21-hydroxylase

1 reference

12 December 2020

Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies

1 reference

12 December 2020

Bone density and turnover in Addison's disease: effect of glucocorticoid treatment

1 reference

12 December 2020

Polyglandular autoimmune endocrine insufficiency complicated by severe osteoporosis

1 reference

12 December 2020

Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease

1 reference

12 December 2020

Steroid analysis in saliva: an overview

1 reference

12 December 2020

Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements

1 reference

12 December 2020

Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency.

1 reference

12 December 2020

Bone mineral density in patients with treated Addison's disease

1 reference

12 December 2020

Primary ovarian insufficiency: autoimmune causes

1 reference

12 December 2020

Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases

1 reference

12 December 2020

Associated autoimmunity in Addison's disease

1 reference

12 December 2020

Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency

1 reference

12 December 2020

Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia

1 reference

12 December 2020

Salivary cortisol reflects serum cortisol: analysis of circadian profiles

1 reference

12 December 2020

Low dose (1 mug) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease

1 reference

12 December 2020

Is the prevalence of Addison's disease underestimated?

1 reference

12 December 2020

Adrenal insufficiency in Smith-Lemli-Opitz syndrome

1 reference

12 December 2020

The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels

1 reference

12 December 2020

Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency

1 reference

12 December 2020

Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate

1 reference

12 December 2020

Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency

1 reference

12 December 2020

The expanding world of primary adrenal insufficiencies

1 reference

12 December 2020

Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction

1 reference

12 December 2020

BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease

1 reference

12 December 2020

Human saliva as a diagnostic specimen

1 reference

12 December 2020

Epidemiological and clinical picture of Addison's disease.

1 reference

12 December 2020

Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease

1 reference

12 December 2020

Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass

1 reference

12 December 2020

Glucocorticoid replacement therapy: are patients over treated and does it matter?

1 reference

12 December 2020

An assessment of optimal hydrocortisone replacement therapy

1 reference

12 December 2020

The natural history of adrenal function in autoimmune patients with adrenal autoantibodies

1 reference

12 December 2020

Adrenal insufficiency

1 reference

12 December 2020

Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens

1 reference

12 December 2020

Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study

1 reference

12 December 2020

Salivary cortisol and the diagnosis of Cushing's syndrome: a coming of age

1 reference

12 December 2020

High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase

1 reference

12 December 2020

Neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay

1 reference

12 December 2020

Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease

1 reference

12 December 2020

Current status of neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement

1 reference

12 December 2020

Mineralocorticoid substitution in pregnant Addisonian women

1 reference

12 December 2020

Plasma lipoproteins and adrenocortical hormones in men--positive association of low density lipoprotein cholesterol with plasma cortisol concentration

1 reference

12 December 2020

Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease

1 reference

12 December 2020

Corticosteroid replacement therapy: twice or thrice daily?

1 reference

12 December 2020

Bone mineral density is reduced in female but not male subjects with Addison's disease

1 reference

12 December 2020

Addison's disease--clinical studies. A report fo 108 cases

1 reference

12 December 2020

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

12 December 2020

Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal

1 reference

12 December 2020

Salivary steroid assays for assessing variation in endocrine activity.

1 reference

12 December 2020

10.1007/S12020-012-9835-4

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23179775